Brittany Lemmon and colleagues’ assessment of the US Food and Drug Administration's (FDA's) proposed front-of-pack label (FOPL) for food products provides timely evidence during an important policy window.1 With the growing burden of diet-related diseases, ensuring consumers have access to clear and accurate information about the nutritional quality of foods at the point of sale or consumption is crucial.2 The provision of this information can in turn encourage food reformulation as producers seek to enhance the competitiveness of their products.
The Lancet Public Health published a clinical update in Infectious Disease on 01 Apr 2026.
The item focuses on Front-of-pack food labelling in the USA.
Review the original article for the full source wording and details.